Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.

Saved in:
Bibliographic Details
Title: Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
Authors: Sekhavati E; Department of Cardiology, Ziayian Hospital, Tehran University of Medical Sciences, Tehran, Iran., Jafari F; Mazandaran University of Medical Sciences, School of Medicine, Sari, Iran; Iran University of Medical Sciences, School of Medicine, Tehran, Iran. Electronic address: fatemejafari72@gmail.com., SeyedAlinaghi S; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Jamalimoghadamsiahkali S; Department of Infectious Diseases, Ziayian Hospital, Tehran University of Medical Sciences, Tehran, Iran., Sadr S; Mazandaran University of Medical Sciences, School of Medicine, Sari, Iran., Tabarestani M; Medical Students Research Committee, Mazandaran University of Medical Sciences, School of Medicine, Sari, Iran., Pirhayati M; Iran University of Medical Sciences, School of Medicine, Tehran, Iran., Zendehdel A; Geriatric Department, Ziayian Hospital, Tehran University of Medical Sciences, Tehran, Iran., Manafi N; Iran University of Medical Sciences, School of Medicine, Tehran, Iran., Hajiabdolbaghi M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Ahmadinejad Z; Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Keshavarz Boulevard, Tehran University of Medical Sciences, Tehran 14197-33141, Iran., Kouchak HE; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Jafari S; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Khalili H; Department of Pharmacotherapy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Salehi M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Seifi A; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Golestan FS; Department of Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran., Ghiasvand F; Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Keshavarz Boulevard, Tehran University of Medical Sciences, Tehran 14197-33141, Iran. Electronic address: ghiasvand_62@yahoo.com.
Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2020 Oct; Vol. 56 (4), pp. 106143. Date of Electronic Publication: 2020 Aug 25.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-7913
DOI:10.1016/j.ijantimicag.2020.106143